Literature DB >> 2085675

Colocalization of estrogen and progesterone receptors with an estrogen-regulated heat shock protein in paraffin sections of human breast and endometrial cancer tissue.

D R Ciocca1, A O Stati, M M Amprino de Castro.   

Abstract

We have studied by immunocytochemistry and monoclonal antibodies the presence and localization of estrogen receptors, progesterone receptors, and a 24-kD estrogen-regulated heat shock protein in biopsies from breast and endometrial cancer patients. Three different tissue processing protocols were used to colocalize the antigens in the same tissue sections: a) frozen sections, b) formalin fixation with routine paraffin embedding, and c) picric acid-formaldehyde (PAF) fixation with a rapid embedding in paraffin. Frozen sections showed good receptor staining but poor 24-kD protein immunoreactivity, while routine paraffin sections (with or without DNase pretreatment) were inadequate to reveal the nuclear receptor proteins at the same level seen in frozen sections. On the other hand, all three proteins could be detected satisfactorily in PAF-fixed paraffin-embedded tissue. Using this procedure we were able to visualize 24-kD protein and estrogen receptor or progesterone receptor in individual cells in paraffin sections. The study revealed that in all of the estrogen receptor positive breast and endometrial tumor samples, almost 90% of the cells expressing the cytoplasmic 24-kD protein contained estrogen receptor in the cell nucleus. In contrast, 24-kD immunoreactive cells did not express progesterone receptors in almost 40% of the progesterone receptor positive tumor samples.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2085675     DOI: 10.1007/BF01806332

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  16 in total

1.  Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer.

Authors:  E R DeSombre; S M Thorpe; C Rose; R R Blough; K W Andersen; B B Rasmussen; W J King
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

2.  Detection of estrogen receptors with monoclonal antibodies in routinely processed formalin-fixed paraffin sections of breast carcinoma. Use of DNase pretreatment to enhance sensitivity of the reaction.

Authors:  I P Shintaku; J W Said
Journal:  Am J Clin Pathol       Date:  1987-02       Impact factor: 2.493

Review 3.  [Hormone-dependent tumors: current concepts].

Authors:  D R Ciocca
Journal:  Medicina (B Aires)       Date:  1988       Impact factor: 0.653

4.  Purification of an estrogen-regulated breast cancer protein by monoclonal antibody affinity chromatography.

Authors:  D J Adams; H Hajj; K G Bitar; D P Edwards; W L McGuire
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

5.  Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7).

Authors:  D P Edwards; D J Adams; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

6.  Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.

Authors:  D R Ciocca; L A Puy; L C Fasoli
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

7.  Induction of the estrogen-regulated "24K" protein by heat shock.

Authors:  S A Fuqua; M Blum-Salingaros; W L McGuire
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

8.  Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity.

Authors:  D R Ciocca; D J Adams; R J Bjercke; G W Sledge; D P Edwards; G C Chamness; W L McGuire
Journal:  J Histochem Cytochem       Date:  1983-05       Impact factor: 2.479

9.  Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors.

Authors:  D J Adams; W L McGuire
Journal:  Cancer Res       Date:  1985-06       Impact factor: 12.701

10.  Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumors.

Authors:  M Perrot-Applanat; M T Groyer-Picard; F Lorenzo; A Jolivet; M T Vu Hai; C Pallud; F Spyratos; E Milgrom
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

View more
  9 in total

1.  Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.

Authors:  D R Ciocca; E H Luque
Journal:  Breast Cancer Res Treat       Date:  1991-12       Impact factor: 4.872

Review 2.  Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications.

Authors:  Daniel R Ciocca; Stuart K Calderwood
Journal:  Cell Stress Chaperones       Date:  2005       Impact factor: 3.667

3.  Progesterone receptors in routinely paraffin-embedded primary breast carcinomas and lymph node metastases.

Authors:  E Müller-Holzner; A G Zeimet; G Daxenbichler; C Marth; L C Müller; O Dapunt
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

4.  Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer.

Authors:  M A Fanelli; L M Vargas-Roig; F E Gago; O Tello; R Lucero De Angelis; D R Ciocca
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Overexpression of 27-kDa heat-shock protein in MCF-7 breast cancer cells: effects on lymphocyte-mediated killing by natural killer and gamma delta T cells.

Authors:  D M Mahvi; S W Carper; F K Storm; S R Teal; P M Sondel
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

6.  Heat-Shock Stress-Response Proteins in Endocrine Pathology.

Authors:  George Kontogeorgos; Kalman Kovacs; Sylvia L. Asa
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

7.  Prognostic significance of heat shock protein 70 expression in early gastric carcinoma.

Authors:  Youngran Kang; Woon Yong Jung; Hyunjoo Lee; Wonkyung Jung; Eunjung Lee; Bong Kyung Shin; Aeree Kim; Han Kyeom Kim; Baek-Hui Kim
Journal:  Korean J Pathol       Date:  2013-06-25

8.  SELDI-TOF proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

Authors:  Bashar A Zeidan; Paul A Townsend
Journal:  Breast Cancer Res       Date:  2008       Impact factor: 6.466

9.  Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression.

Authors:  Kristyna Brozkova; Eva Budinska; Pavel Bouchal; Lenka Hernychova; Dana Knoflickova; Dalibor Valik; Rostislav Vyzula; Borivoj Vojtesek; Rudolf Nenutil
Journal:  Breast Cancer Res       Date:  2008-05-29       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.